Noble Capital Starts Helius Medical Tech (HSDT) at Outperform
- Wall Street falls with Amazon; S&P 500 posts sixth straight month of gains
- Amazon (AMZN) Plunges After Missing Sales and Guidance Expectations, Analysts Slash PTs to Reflect Weaker Guidance
- Pinterest (PINS) Tops Profit and Sales Views, But Shares Plunges Over 20% on a Big Monthly User Miss to Prompt Two Downgrades
- 'I'm CEO.' New Book Outlines Merger Conversations Between Elon Musk and Tim Cook
- Bullard: Fed should taper this fall, go "fairly rapidly" to end early 2022
Noble Capital analyst Joe Gomes initiates coverage on Helius Medical Tech (NASDAQ: HSDT) with a Outperform rating and a price target of $20.00.
Shares of Helius Medical Tech closed at $14.12 yesterday.
You May Also Be Interested In
- UPDATE: Needham & Company Starts N-Able Inc. (NABL) at Buy Post-Spin
- BTIG Starts Riot Blockchain (RIOT) at Buy
- BTIG Resumes 89bio Inc. (ETNB) at Buy
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!